Modeling the impact of amino acid substitution in a monoclonal antibody on cation exchange chromatography
Open Access
- 19 April 2021
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 118 (8) , 2923-2933
Abstract
A vital part of biopharmaceutical research is decision making around which lead candidate should be progressed in early‐phase development. When multiple antibody candidates show similar biological activity, developability aspects are taken into account to ease the challenges of manufacturing the potential drug candidate. While current strategies for developability assessment mainly focus on drug product stability, only limited information is available on how antibody candidates with minimal differences in their primary structure behave during downstream processing. With increasing time‐to‐market pressure and an abundance of mAbs in development pipelines, developability assessments should also consider the ability of mAbs to integrate into the downstream platform. This study investigates the influence of amino acid substitutions in the complementarity‐determining region (CDR) of a full‐length IgG1 mAb on the elution behavior in preparative cation exchange (CEX) chromatography. Single amino acid substitutions within the investigated mAb resulted in an additional positive charge in the light chain (L) and heavy chain (H) CDR, respectively. The mAb variants showed an increased retention volume in linear gradient elution compared to the wild type antibody. Further, the substitution of tryptophan with lysine in the H‐CDR3 increased charge heterogeneity of the product. A multi‐scale in silico analysis, consisting of homology modeling, protein surface analysis, and mechanistic chromatography modeling increased understanding of the adsorption mechanism. The results reveal the potential effects of lead optimization during antibody drug discovery on downstream processing.Keywords
This publication has 59 references indexed in Scilit:
- Molecular Simulations of Multimodal Ligand–Protein Binding: Elucidation of Binding Sites and Correlation with ExperimentsThe Journal of Physical Chemistry B, 2011
- PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKaPredictionsJournal of Chemical Theory and Computation, 2011
- Recovery and purification process development for monoclonal antibody productionmAbs, 2010
- Heterogeneity of Monoclonal AntibodiesJournal of Pharmaceutical Sciences, 2008
- Chromatographic separation of three monoclonal antibody variants using multicolumn countercurrent solvent gradient purification (MCSGP)Biotechnology and Bioengineering, 2008
- Quality by design—Thermodynamic modelling of chromatographic separation of proteinsJournal of Chromatography A, 2008
- Development, modelling, optimisation and scale-up of chromatographic purification of a therapeutic proteinFluid Phase Equilibria, 2007
- Downstream processing of monoclonal antibodies—Application of platform approachesJournal of Chromatography B, 2007
- Steric mass‐action ion exchange: Displacement profiles and induced salt gradientsAIChE Journal, 1992
- Resolution of proteins in linear gradient elution ion-exchange and hydrophobic interaction chromatographyJournal of Chromatography A, 1987